RELIFE 瑞來生物科技

Precision cell science, built around each patient.

Relife develops customized biomedical solutions based on cancer vaccine and NK cell science, guided by patient-derived organoids and AI, and provided only through registered doctors.

Based in
Hong Kong
Core science
Cancer vaccine and NK cells
Approach
Built around each patient

Precision cellsAI-drivenA healthier future

精準細胞 × AI驅動 × 更健康的未來

We imagine a future where medicine is designed from each person’s own cells, and where AI turns those signals into insight in days, not years.

Read our vision

Four technologies, one integrated platform.

Our platform brings these technologies together, with the patient’s own cells at the center.

YouCancer vaccineNK cellsOrganoidsAI analysis

Personalized cancer vaccine

個人化癌症疫苗

Designed from the unique mutations of each patient’s tumor, to present these targets to the immune system.

NK cell technology

NK細胞技術

Natural killer cells are part of the innate immune system, which can recognize abnormal cells.

Organoid-guided testing

類器官藥敏測試

Miniature tumors grown from the patient’s own sample, used to compare options in the laboratory first.

AI precision analysis

AI精準分析

AI helps analyze genomic, imaging and laboratory data. Every result is reviewed by scientists and doctors.

How we work with doctors.

We work with the patient’s treating doctor at every step. Medical decisions are always made by the doctor, together with the patient.

  1. 01

    Refer

    The treating doctor refers the patient, with the patient’s consent, and shares the relevant clinical information.

  2. 02

    Profile

    With consent, a tumor and blood sample is analyzed genomically and grown as organoids.

  3. 03

    Report

    AI-assisted analysis, reviewed by our scientists, is summarized in a report for the doctor.

  4. 04

    Doctor’s decision

    The treating doctor decides whether and how to proceed. Any treatment is given by a registered doctor under applicable Hong Kong regulations.

Conceptual illustration of a tumor organoid.

Patient tumors, studied in the lab.

From a small sample, we grow patient-derived organoids that keep key features of the original tumor.

Laboratory results from these organoids can give the treating doctor additional information. Organoid results alone do not predict how a treatment will work in the body.

Let’s talk about precision cell science.

Doctors can refer a patient, and hospitals, laboratories and investors can explore a partnership. Patients are welcome to contact us; any medical decision is made with your own doctor.